ClinicalTrials.Veeva

Menu

The Blended Care Intervention "Booster" for Youth With Chronic Health Conditions to Increase Fatigue-related Self-efficacy

U

UMC Utrecht

Status

Not yet enrolling

Conditions

Chronic Illnesses
Fatigue

Treatments

Other: Booster

Study type

Interventional

Funder types

Other

Identifiers

NCT06562335
24U-0152

Details and patient eligibility

About

The goal of this experimental study is to learn if the Booster intervention can be used as an early intervention for persistent fatigue. The aim of the intervention is to prevent more fatigue-related disabilities in young people with chronic illnesses like inflammatory bowel disease, childhood cancer, and juvenile idiopathic arthritis by improving self-confidence in managing fatigue (fatigue-related self-efficacy or FSE).

The main questions this study aims to answer are:

  • What is the effect of the Booster intervention on fatigue-related self-efficacy (FSE)?
  • What is the effect of the Booster intervention on fatigue levels, school participation, life satisfaction, and perceived health?
  • When does improvement in study outcomes happen relative to the Booster intervention?
  • What participant characteristics predict change in study outcomes?

Participants will follow the Booster intervention. Booster is a personalised, blended care intervention designed to help young people understand how their thoughts, feelings, and activities impact their fatigue using a smartphone app. The Booster app uses experience sampling methodology (ESM) to track these fluctuations. Based on insights obtained from these data, the participant and their healthcare provider can set personal lifestyle goals, such as increasing physical activity and reducing daytime naps. An earlier version of this intervention, called PROfeel, was effective in reducing severe fatigue. The investigators have now improved the app to also help with setting and achieving personal goals and monitoring daily progress.

The investigators will measure the effect of Booster through daily questionnaires during two phases: Phase A (baseline, before the goal setting between patient and healthcare provider) and Phase B (intervention, starting in the lifestyle change period). The duration of Phase A will be randomised for each participant.

Enrollment

20 estimated patients

Sex

All

Ages

12 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Experiencing fatigue for at least 3 months and feeling hindered by it (Pediatric Short Fatigue Questionnaire (pSFQ) score of 15 or higher)
  • Diagnosed with a chronic health condition or treated for childhood cancer

Exclusion criteria

Regarding other treatments:

  • Fatigue fully explained by a somatic or psychiatric diagnosis
  • Chronic health condition unstable in the last 3 months (e.g., recent medication changes or cancer relapse)
  • Significant functional limitations due to fatigue (e.g., more than 50% school absenteeism)

Regarding feasibility:

  • Cognitive impairment with an estimated IQ of below 70
  • No smartphone with internet access
  • Unable to speak, read, understand, or write Dutch

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Booster intervention
Experimental group
Description:
* Start conversation: participant personalises the Booster app, supported by the Booster practitioner * Measurement period: the participant fills out short repeated questionnaires 5 times daily for 4 weeks in the Booster app. This method is called experience sampling methodology (ESM). Questions are partially personalised to reflect factors that the participants believes are related to fatigue. Questions cover thoughts, feelings, and activities. * Insight conversation: the Booster practitioner discusses the analysed questionnaires with the participant. Together they set lifestyle goals based on the insight obtained. * Experiment period: the participant works on the lifestyle goals supported by the goal attainment module in the Booster app.
Treatment:
Other: Booster

Trial contacts and locations

1

Loading...

Central trial contact

MD Stutvoet, MSC, M.D.; A Vroegindeweij, MSC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems